Regulator restricts use of SSRIs in childrenBMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7498.984-a (Published 28 April 2005) Cite this as: BMJ 2005;330:984
- Lynn Eaton
The European Medicines Agency has ruled that selective serotonin reuptake inhibitors (SSRIs) and selective serotonin and norepinephrine reuptake inhibitors (SNRIs) should not be prescribed for children and adolescents under the age of 18, except for limited, approved uses. Some of the drugs have been approved for obsessive compulsive disorder, and one of them has been approved for attention deficit/hyperactivity disorder.
It is also recommending that strong warnings should be issued throughout the European Union about the potential risk of suicidal behaviour and aggression in these age groups.
The advice …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial